[
    [
        {
            "time": "",
            "original_text": "益丰药房(603939.SH)年度归母净利润增41.29%至7.68亿元 拟每10股派3元及转增3股",
            "features": {
                "keywords": [
                    "益丰药房",
                    "净利润",
                    "增长",
                    "派息",
                    "转增"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "益丰药房(603939.SH)年度归母净利润增41.29%至7.68亿元 拟每10股派3元及转增3股",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "益丰药房(603939.SH)2020年度净利润升41.29%至7.68亿元 拟10转3派3元",
            "features": {
                "keywords": [
                    "益丰药房",
                    "2020年度",
                    "净利润",
                    "增长",
                    "转增",
                    "派息"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "益丰药房(603939.SH)2020年度净利润升41.29%至7.68亿元 拟10转3派3元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "益丰药房：2020年净利润同比增长41.29%",
            "features": {
                "keywords": [
                    "益丰药房",
                    "2020年",
                    "净利润",
                    "同比增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "益丰药房：2020年净利润同比增长41.29%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物板块涨0.46% 未名医药和双鹭药业涨停",
            "features": {
                "keywords": [
                    "医药生物",
                    "板块",
                    "上涨",
                    "未名医药",
                    "双鹭药业",
                    "涨停"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物板块涨0.46% 未名医药和双鹭药业涨停",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "八大券商主题策略：“药”不能停！业绩炸裂的一季报 只是开始不是结束",
            "features": {
                "keywords": [
                    "券商",
                    "主题策略",
                    "医药",
                    "业绩",
                    "一季报",
                    "增长"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "八大券商主题策略：“药”不能停！业绩炸裂的一季报 只是开始不是结束",
                "Correlation": 4,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        }
    ]
]